Centene forecasts 2026 adjusted EPS greater than $5.20 as Medicare turnaround reaches breakeven a year early (NYSE:CNC)
Centene (CNC) reported Q3 2026 adjusted EPS of $0.58, exceeding expectations. The company forecasts 2026 adjusted EPS to exceed $5.20, with its Medicare turnaround reaching breakeven a year early, according to CEO Sarah London.
How this was made
The 30-second read
Why it matters
The raised EPS guidance is a fresh, material data point for investors.
Market read
New guidance may drive short‑term price appreciation for CNC.
What to watch
Potential cost pressures from rising medical expenses could offset the earnings boost.
Background
Centene's earnings call provided the latest quarterly results and forward guidance.
Ticker impact
Centene reported Q3 adjusted EPS of $0.58 and raised its 2026 adjusted EPS guidance to above $5.20.
potential upside as market prices in the improved earnings outlook
The new EPS guidance exceeds prior expectations for a large‑cap health insurer, a material catalyst for investors.
Market effects
Positive for the health insurance sector as the outlook improvement may lift peers.
U.S. market may see modest buying pressure in the healthcare segment.
Limited; primarily affects U.S. investors focused on health insurers.
Counterpoint
If the guidance assumes optimistic Medicare reforms, any policy reversal could negate the upside.
Key entities
- CompanyCentene Corporation
U.S. health insurer providing Medicare Advantage plans.



